Results 171 to 180 of about 14,304 (250)

Urokinase Promotes Redundantly Intratubular C3a-Formation But Not ENaC-Driven Hypertension in DOCA/Salt Kidney Injury. [PDF]

Hypertension
Bach ML, Enggaard C, Thangaraj SS, Heinl A, Svenningsen P, Palarasah Y, Jensen BL.   +6 more
europepmc   +1 more source

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain

, 2017
Despite the fact that ischemic stroke has been considered a leading cause of mortality in the world, recent advances in our understanding of the pathophysiological mechanisms underlying the ischemic injury and the treatment of acute ischemic stroke ...
Paola Merino, Ariel Diaz, Manuel Yepes
core  

Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. [PDF]

Clin Exp Metastasis
Spartz A, Schmidt S, Mohamed F, Troness B, Lange CA, El-Ashry D.   +5 more
europepmc   +1 more source

Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness. [PDF]

Am J Respir Cell Mol Biol
Whitehead GS, Nakano K, Wilkinson CL, Patterson AM, Upadhyay S, Massri AJ, Papas BN, Gruzdev A, Ray M, Nakano H, Cook DN.   +10 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]

Diabetes Care
Sakr SM, Desai S, Medina-Inojosa J, Liu C, Razavi AC, Yadalam AK, Ko YA, Ahmed T, Harris KA, Huang J, Yeboah R, Haroun N, Hartsfield JD, Owais M, Lodhi R, Eldaidamouni AA, Al Kasem M, Ali MK, Narayan KMV, Pasquel FJ, Tandon N, Mohan V, Quyyumi AA.   +22 more
europepmc   +1 more source

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]

Neuromolecular Med
de Rezende VL, Mathias K, Danielski LG, Barichello T, Petronilho F.   +4 more
europepmc   +1 more source

Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies. [PDF]

Transl Oncol
Wang CC, Barkholt P, Wozniak A, Vanleeuw U, Lee CJ, De Sutter L, De Cock L, Verbeeck K, Engelholm LH, Lynch C, Mumberg D, Schöffski P.   +11 more
europepmc   +1 more source

Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer. [PDF]

Explor Target Antitumor Ther
Izuegbuna OO.
europepmc   +1 more source

Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]

Front Oncol
Al Shaer NSH, Tleyjeh A, Al-Attas MA, Alibrahim JH, Khan MI, Yaqinuddin A.   +5 more
europepmc   +1 more source

Targeted Interference with USF2 Binding to the SERPINE1 Proximal Promoter E-Box in Dual Mutant p53^R282Q,H179Y Human Keratinocytes Inhibits Serum-/TGF-β1-Induced SERPINE1 Expression and Stimulates Epithelial Cell Proliferation. [PDF]

Biomedicines
Higgins SP, Czekay RP, Higgins CE, Higgins PJ.   +3 more
europepmc   +1 more source